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Introduction
Prostaglandins (PGs) are well-recognized mediators of
many important biologic processes (1). They exert their
effects through binding to a family of G protein–coupled
receptors (2). Among PGs, prostaglandin E2 (PGE2) is
unique in that it acts through 4 different receptors
(EP1–EP4), each with distinct but overlapping tissue dis-
tributions that activate different intracellular signaling
pathways (3). It has been postulated that this complexi-
ty underlies the broad spectrum of physiologic respons-
es that can be mediated by PGE2 and that specific recep-
tors will be associated with each of these responses (4).
A role for PGs in reproductive physiology has been rec-
ognized for many years. PGs are present throughout the
female reproductive tract, and the entire reproductive
process is believed to be under the influence of these lipid
mediators (5). Early studies showed that several aspects of
female reproduction could be affected by inhibitors of PG
synthesis (6, 7). Furthermore, genes encoding prostanoid
receptors are expressed in both a temporal and cell-spe-
cific fashion during key events of early pregnancy (8, 9).
More recently, mice deficient in cyclooxygenase-2 (COX-
2), the rate-limiting enzyme in synthesis of all prostanoids
during pregnancy, including PGE2, have been generated.
These mice are infertile, with abnormalities in ovulation,
fertilization, implantation, and decidualization (10). How-
ever, because COX-2 is critical for the production of PGE2,
PGD2, PGF2, PGI2 (prostacyclin), and thromboxane A2,
these studies did not identify the particular prostanoid or
receptor critical to each of the reproductive functions dis-
rupted in these animals. Some insight into the mecha-
nism by which prostanoids mediate their effects is begin-
ning to emerge from the study of animals deficient in
specific receptors. For example, mice deficient in the
receptor for PGF (FP receptor) demonstrated failure of
parturition but showed no abnormalities in ovulation, fer-
tilization, or implantation (11).
Surprisingly, no decreased fertility has been reported for
the EP3-, EP4-, thromboxane (TP)-, or prostacyclin (IP)-
receptor–deficient mice, despite the expression of these
prostanoid receptors in the reproductive tract (8, 9, 12–16).
PGE2 also has potent effects on the cardiovascular sys-
tem. A role for PGE2 in blood pressure homeostasis has
been recognized for years, but its effects are complex
because it acts on multiple tissues important to the
maintenance and control of blood pressure (17).
Although it is clear that blood pressure homeostasis and
many aspects of female reproduction may be regulated
by PGs, the precise contribution of the individual recep-
tors that mediate the actions of PGE2 remains to be
defined. Utilizing mice deficient in the EP2 receptor, we
show that this PG receptor plays a critical role in suc-
cessful fertilization of the released ovum and the main-
tenance of circulatory homeostasis.
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Prostaglandins (PGs) are bioactive lipids that modulate a broad spectrum of biologic processes includ-
ing reproduction and circulatory homeostasis. Although reproductive functions of mammals are influ-
enced by PGs at numerous levels, including ovulation, fertilization, implantation, and decidualization,
it is not clear which PGs are involved and whether a single mechanism affects all reproductive functions.
Using mice deficient in 1 of 4 prostaglandin E2 (PGE2) receptors — specifically, the EP2 receptor — we
show that Ep2–/– females are infertile secondary to failure of the released ovum to become fertilized in
vivo. Ep2–/– ova could be fertilized in vitro, suggesting that in addition to previously defined roles, PGs
may contribute to the microenvironment in which fertilization takes place. In addition to its effects on
reproduction, PGE2 regulates regional blood flow in various vascular beds. However, its role in systemic
blood pressure homeostasis is not clear. Mice deficient in the EP2 PGE2 receptor displayed resting sys-
tolic blood pressure that was significantly lower than in wild-type controls. Blood pressure increased in
these animals when they were placed on a high-salt diet, suggesting that the EP2 receptor may be
involved in sodium handling by the kidney. These studies demonstrate that PGE2, acting through the
EP2 receptor, exerts potent regulatory effects on two major physiologic processes: blood pressure home-
ostasis and in vivo fertilization of the ovum.
J. Clin. Invest. 103:1539–1545 (1999).
Methods
Animal welfare. The use of experimental animals was in accor-
dance with the Institutional Animal Care and Use Committee
(IACUC) guidelines of the University of North Carolina–Chapel
Hill and Duke University.
Generation of Ep2–/– mice. Genomic clones were isolated from
a 129/Sv mouse genomic library with an Ep2 cDNA probe and
their identity confirmed by sequence analysis. A targeting vec-
tor was constructed in which the DNA encoding amino acids
246–601 was replaced by a neomycin-resistant gene and elec-
troporated into 129/Ola–derived E14TG2a embryonic stem
(ES) cells, and neomycin- and ganciclovir-resistant colonies
were identified using standard methods (18). DNA isolated
from ES cell colonies was digested with the restriction enzyme
HindIII and analyzed by Southern blot to identify clones with
a targeted Ep2 allele. Chimeras derived from targeted ES cells
were mated with 129/SvEv mice, and offspring carrying the
targeted allele were identified by Southern blot analysis. These
heterozygotes were intercrossed to produce mice homozygous
for the Ep2 mutation.
Analysis of Ep2 RNA expression. Total uterine RNA was isolated
from 7-week-old Ep2–/– and Ep2+/+ mice using RNAzol (Tel-
Test Inc., Friendswood, Texas, USA) according to the 
manufacturer’s specifications. Ep2 and actin cDNA were 
synthesized by reverse transcription, and PCR 
amplification was carried out using the following oligonu-
cleotide primers: Ep2-1F (5′-GTGGCCCTGGCTCCC-
GAAAGTC-3′), Ep2-2R (5′-GGCAAG-GAGCATATGGC-
GAAGGTG-3′),actin-1F(5′-TAAGGCCAACCGTGAAAAGAT
GAC-3′), and actin-2R (5′-ACCGCTCGTTGCCAATAGT-
GATG-3′). The PCR products were analyzed by gel elec-
trophoresis and staining with ethidium bromide.
Blastocyst transfer. Ep2–/– and Ep2+/+ females (8–22 weeks old)
were mated with wild-type vasectomized males and checked
daily for vaginal plugs. Fourteen to 20 C57BL/6 blastocysts
were transferred into the uteri of recipient females on day 3.5
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Figure 1
Disruption of the gene encoding the EP2 receptor. (a) Restriction maps of the targeting construct, endogenous locus, and targeted locus. The dark filled
box represents exon sequences of the Ep2 gene. The open boxes represent phosphoglycerate kinase-thymidine kinase (PGK-TK) and PGK-Neo selection
cassettes. Homologous recombination of the targeting vector with the endogenous locus results in deletion of a 355-bp segment of DNA that is pre-
dicted to encode 3 transmembrane domains and 2 intracellular loops of mature EP2 protein. The hatch filled box represents the probe used to detect
homologous recombination events by Southern blot analysis. Relevant restriction sites are abbreviated by the following: B, BamHI; E, EagI; H, HindIII; L,
BglI; N, NsiI; Nt, NotI; R, EcoRI; S, SacII. Note that not all HindIII sites are mapped. (b) Southern blot analysis of DNA obtained from tail biopsies of off-
spring from Ep2+/– heterozygote breedings. HindIII-digested DNA was analyzed using a 1.1-kb EcoRI probe corresponding to DNA outside the targeted
region of the Ep2 gene. This probe detects a 7-kb band derived from the endogenous locus and an 8.5-kb band from the targeted locus. (c) RT-PCR ampli-
fication of Ep2 total RNA from uteri of Ep2–/– and Ep2+/+ mice. Ep2-specific cDNA was synthesized by RT-PCR. The left lanes represent cDNA from 2 Ep2–/–
animals; the lane on the far right represents cDNA from an Ep2+/+ animal. To ensure that the failure to detect an Ep2-specific DNA fragment in the mRNA
obtained from Ep2–/– animals was not due to the absence of RNA, the same samples were subjected to RT-PCR using actin-specific primers.
of pseudopregnancy, and the foster mothers were checked
daily for pregnancy and delivery.
Ovulation and fertilization. Ep2–/– and Ep2+/+ mice were mated
with wild-type males, and inspection for vaginal plugs was per-
formed daily. On the day after finding a vaginal plug, mice were
sacrificed and oviducts were flushed with 100–200 µL of CO2-
independent media to recover eggs or embryos.
In vitro fertilization. Female mice were superovulated by inject-
ing 5 IU pregnant mare’s serum intraperitoneally and then, 48
hours later, injecting 5 IU human chorionic gonadotropin
(hCG) intraperitoneally. Twelve hours after hCG was injected,
mice were sacrificed and the ova were collected and incubated in
HTF media for 4–6 hours at 37°C with sperm collected from the
epididymides of proven male mice. The ova were then washed
and cultured for an additional 24 hours, at which time the num-
ber of unfertilized eggs and 2-cell embryos was determined.
Blood pressure measurements. Resting systolic blood was meas-
ured in conscious female mice (3–4 months old) using a com-
puterized noninvasive tail-cuff system (Visitech Systems, Apex,
North Carolina, USA). The validity of this system has been
demonstrated previously (19). Mice were adapted to the system
for 5 days, after which blood pressure was recorded daily for 5
consecutive days after 2 weeks of either a normal (0.4% NaCl)
or high-salt diet (6% NaCl; Harlan Teklad Laboratory, Madison,
Wisconsin, USA), ad libitum, with free access to water.
Plasma electrolytes. Blood was collected by cardiac puncture
into cold EDTA-coated tubes, and plasma samples were imme-
diately placed at –80°C. Plasma sodium levels were determined
by flame photometry.
Twenty-four–hour urine collections for PGE2 determination. Urine
was collected over a 24-hour period using a mouse metabolic
cage, and stored at –20°C immediately upon completion of the
study period. Urinary PGE2 was determined by enzyme
immunoassay according to the manufacturer’s protocol (Cay-
man Chemicals, Ann Arbor, Michigan, USA).
Plasma renin activity. Plasma renin concentration was deter-
mined by radioimmunoassay according to the manufactur-
er’s protocol (Du Pont NEN Research Products, Boston,
Massachusetts, USA).
Renin mRNA. Kidneys were harvested from Ep2–/– and Ep2+/+
mice, frozen in liquid nitrogen, and immediately placed at
–80°C. Total RNA was extracted by homogenization with RNA-
zol (Tel-Test Inc.) according to the manufacturer’s specifica-
tions. Renin mRNA was measured by RNase protection assay
as described previously (20).
Statistical analysis. Data are presented as mean ± SEM. Statis-
tical significance was assessed by using χ2 analysis and the
unpaired Student’s t test.
Results
Generation of Ep2–/– mice. Mouse ES cells in which the Ep2
gene was disrupted by homologous recombination were
generated using the scheme shown in Figure 1a. Chimeric
animals created with these targeted cells were mated with
129/SvEv mice to generate heterozygotes for the mutant
allele on the 129 background. Heterozygous Ep2+/– mice
were intercrossed and Ep2–/– offspring were born at
expected frequencies — 25.2% (Ep2+/+), 50% (Ep2+/–), and
24.7% (Ep2–/–) — indicating that this receptor does not
have a unique role in intrauterine development or peri-
natal survival (Figure 1b). The appearance, behavior, and
longevity of Ep2–/– mice did not differ from that of wild-
type littermates, with some mice living longer than 18
months. Gross and histologic appearance of all major
organs, including the kidney, uterus, and ovaries, did not
differ between Ep2–/– and wild-type animals. Loss of Ep2
expression was verified by RT-PCR analysis of RNA from
Ep2–/– animals (Figure 1c).
Fertility of the EP2-deficient animals. Whereas Ep2–/– males
were fertile, fertility was severely impaired in Ep2–/–
females. After 12 weeks of mating, only 6 of 34 (18%)
Ep2–/– females achieved pregnancy and delivered litters,
compared with 39 of 42 (93%) Ep2+/– females (P = 0.001).
This reduced fertility of the Ep2–/– females did not reflect
a decrease in the frequency of mating, as determined by
the presence of vaginal plugs.
Blastocyst transfer. To determine if reproductive failure
was due to defective implantation of the embryos, wild-
type blastocysts were transferred into the uteri of Ep2–/–
and Ep2+/+ animals on day 3.5 of pseudopregnancy. As
shown in Table 1, eight successful pregnancies were
achieved through blastocyst transfer into Ep2–/– females,
with 60 out of 191 blastocysts developing into embryos
(31% efficiency). These results are not significantly dif-
ferent from those obtained in Ep2+/+ females (Table 1).
Gestational time was similar for both groups of animals
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Figure 2
Ovulation and fertilization in Ep2–/– and Ep2+/+ mice.
Female Ep2–/– (n = 8) and Ep2+/+ (n = 5) mice were
mated with wild-type males, and ovulation and in vivo
fertilization were determined by counting eggs and
embryos 2 days following coitus. For in vitro fertiliza-
tion, eggs from mice of both genotypes were collected
12 hours after ovulation and cultured with sperm
obtained from wild-type males. Fertilization was scored
by counting the number of 2-cell embryos 24 hours
later. *P < 0.0001.
(17.2 ± 0.2 vs. 17.8 ± 0.5 days), as was the care of the pups.
To confirm the previously observed infertility, the same
female mice used for blastocyst transfer were then mated
with fertile males. Whereas 8 of 8 Ep2+/+ females became
pregnant, successful pregnancies developed in only 3 of
the 12 Ep2–/– mice (P = 0.004). Furthermore, litter sizes of
those Ep2–/– females achieving pregnancy were signifi-
cantly smaller than litters from Ep2+/+ females (5.2 ± 0.8 vs.
1.3 ± 0.3; P = 0.004). These experiments demonstrate that
the effects of the Ep2 mutation on fertility are not due to
defective implantation, decidualization, or parturition.
Ovulation and fertilization. We next examined ovulation
and fertilization in Ep2–/– and Ep2+/+ mice. Histologic
examination of the ovaries revealed normal numbers of
primary and mature follicles in the 2 mouse lines. As
shown in Table 1, all Ep2–/– females ovulated, and the
number of eggs released per mouse was similar to wild-
type controls (6.9 ± 0.8 vs. 8.6 ± 0.7; P = 0.13). Further-
more, administration of gonadotropic hormones stim-
ulated release of eggs to a similar extent in the 2 groups
of animals (11.8 ± 1.9 vs. 15.6 ± 1.9; P = 0.165)
Fertilization, however, was severely impaired in Ep2–/–
mice. Only 4% (2/55) of eggs from 8 Ep2–/– mice were fer-
tilized, compared with 88% (38/43) of eggs from 5 Ep2+/+
mice (P < 0.0001) (Figure 2). Morphologically, eggs and
their cumulus complexes from Ep2–/– animals were indis-
tinguishable from those of wild-type controls. Motile
sperm were present in the oviducts of Ep2–/– females and
wild-type females 12 hours postcoitus, suggesting that
alterations in sperm transport were not the underlying
cause of fertilization failure for the Ep2–/– ovum. To
exclude the possibility that fertilization failure was sec-
ondary to delayed ovulation, experiments were repeated
with mice in which ovulation was hormonally induced.
Whereas 64 of 102 eggs released from 6 Ep2+/+ females
were fertilized, none of the 61 eggs released from 5 Ep2–/–
females were fertilized (P < 0.001).
To determine whether fertilization failure was second-
ary to abnormalities of the ovum, in vitro fertilization
was performed with ova from Ep2–/– and Ep2+/+ mice. Sev-
enty-one percent of eggs obtained from 4 Ep2–/– females
were successfully fertilized in vitro, similar to in vitro fer-
tilization rates in control eggs (Figure 2).
Blood pressure regulation. To define the role of the EP2
receptor in regulating blood pressure, we compared sys-
tolic blood pressure in conscious Ep2–/– and Ep2+/+
mice. In animals maintained on a normal diet (0.4%
NaCl), systolic blood pressure was reduced significant-
ly in the Ep2–/– mice compared with wild-type controls
(109 ±3 vs. 122 ± 5 mmHg; P = 0.04) (Table 2). To
determine whether this blood pressure difference could
be overcome by providing excess sodium in the diet, we
fed Ep2–/– and Ep2+/+ mice a high-salt diet containing 6%
NaCl. This alteration of dietary NaCl content had no
effect on blood pressure in the wild-type mice. In con-
trast, blood pressure increased significantly in Ep2–/–
mice on a high-salt diet, from 109 ± 3 to 117 ± 3 mmHg
(P = 0.01). Plasma sodium levels and urinary PGE2
excretion were no different between Ep2–/– and Ep2+/+
animals (data not shown).
To evaluate the effect of the Ep2 mutation on regula-
tion of the renin-angiotensin system, and its potential
contribution to altered blood pressure regulation, we
also measured plasma renin activity (PRA) in the 2
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Figure 3
PRA in Ep2–/– and Ep2+/+ mice on normal and high-salt diets.
Plasma was prepared from Ep2–/– (n = 8) and Ep2+/+(n = 7) mice
on a normal diet (0.4% NaCl), and PRA was determined by
radioimmunoassay. PRA was also measured in Ep2–/– (n = 5) and
Ep2+/+(n = 6) mice after 10 days on a high-salt diet (6% NaCl).
Data represent mean ± SEM.
Table 1
Implantation, ovulation, and fertilization
(+/+) (–/–) P value
Blastocyst transfer
No. of recipients 8 12
Pregnancies 6 (75%) 8 (67%) NS
No. of blastocysts 124 191 NS
Successful transfers 42 (34%) 60 (31%) NS
Ovulation (spontaneous)
Mice ovulating 5/5 (100%) 8/8 (100%) NS
Total eggs 43 55 NS
Eggs per mouse 8.6 ± 0.7 6.9 ± 0.8 NS
Ovulation (hormonally induced)
Total eggs 172 130 NS
Eggs per mouse 15.6 ± 1.9 11.8 ± 1.9 NS
Fertilization (in vivo)
Eggs fertilized 38/43 (88%) 2/55 (4%) P = 0.003
(spontaneous ovulation)
Eggs fertilized 64/102 (63%) 0/61 (0%) P < 0.0001
(hormonally induced ovulation)
Fertilization (in vitro)
Eggs fertilized 26/33 (79%) 22/31 (71%) NS
NS, not significant.
groups of mice on the different dietary NaCl regimens.
Figure 3 shows the changes in PRA measured in mice
on normal and high-salt diets. Despite the differences
in blood pressure between Ep2–/– and Ep2+/+ mice on a
normal (0.4% NaCl) diet, PRAs were virtually identical
(12.4 ± 3.0 [n = 8] vs. 15.8 ± 7.0 [n = 7] Ang I/ng/h; 
P = 0.63) (Figure 3). Renin mRNA levels were also sim-
ilar between genotypes (26.9 ± 5.6 vs. 25.5 ± 1.5 pg/µg
total RNA) (Figure 4). After 10 days on the high-salt
diet, PRA was suppressed appropriately in both Ep2–/–
and Ep2+/+ mice (2.4 ± 0.7 [n = 5] vs. 3.8 ± 1.1 [n = 6] Ang
I/ng/h; P = 0.34) (Figure 3).
To determine if the reproductive failure of Ep2–/–
females was related to the reduced blood pressure of these
animals, fertilization was examined after 10 days on a
high-salt diet (6% NaCl). Only 3% of eggs from Ep2–/–
mice were fertilized, compared with 93% of eggs from
Ep2+/+ mice (n = 6; P < 0.0001). These results suggest that
the impaired fertilization in Ep2–/– females is independ-
ent of the hemodynamic changes seen in these animals.
Discussion
We report here on the generation of mice deficient in the
expression of the PGE2 EP2 receptor. Although these mice
are generally healthy, female Ep2–/– mice have significant-
ly reduced pregnancy rates, and when these animals do
become pregnant, they deliver smaller litters than
Ep2+/–and wild-type controls. We show that this decrease
in fertility is primarily due to a significantly lower fertil-
ization rate in the Ep2–/– females. This reduction in fertil-
ization is not due to an intrinsic defect of the ovum,
because the in vitro fertilization rates of the Ep2–/– and
wild-type ova are identical. In addition to this decreased
fertility, we show that Ep2–/– animals have reduced blood
pressure on normal diets and that this hypotension can be
partially ameliorated by increased dietary salt.
Although all 4 EP receptors are expressed in the uterus,
reduced fertility has not been reported for either the
EP3- or EP4-deficient mice (13, 16). Although the fertil-
ity of the EP2-deficient mouse is decreased, implantation
and decidualization is identical to that seen in wild-type
animals. Decreased implantation or decidualization was
not reported for the FP-, IP-, or TP-receptor–deficient
mice (11, 12, 21). These observations are somewhat sur-
prising given the abnormalities of these reproductive
functions in the COX-2–deficient mice. A number of
explanations for these findings can be put forth. First, it
is possible that PGD2 or PGE2 activation of EP1 is impor-
tant for implantation. It is also possible that, despite the
seemingly unique pattern of expression of the various
prostanoid receptors, their functions overlap enough
that implantation is not affected by the loss of a single
receptor. Alternatively, a yet to be identified COX-2 prod-
uct might be important for implantation.
Although ovulation is primarily triggered by a surge of
luteinizing hormone, a role for PGs in this process has
also been suggested. For example, inhibitors of PG syn-
thesis, such as indomethacin, can prevent follicular rup-
ture, and this effect can be overcome by administration
of PGE2 (22). Similarly, mice deficient in COX-2 demon-
strated impaired ovulation (10). Our results indicate that
these effects of PGs on ovulation are not mediated
through the EP2 receptor, because both natural and
hormonally induced ovulation in Ep2–/– females were no
different from wild-type controls.
Although PGs are produced throughout the female
reproductive tract and by ovulated cumulus cell-oocyte
complexes, their precise role in the fertilization process
remains unclear (23). Again, direct evidence for a role of
prostanoids in fertilization came from studies of the
COX-2–deficient mice. The results presented here are
consistent with the hypothesis that at least one function
of prostanoids in fertilization is mediated by PGE2
through the EP2 receptor. To define the mechanism by
which loss of the EP2 receptor leads to decreased fertil-
ization, a number of experiments were carried out. To
determine if decreased fertilization was due to delayed or
premature release of the ovum, ovulation was induced by
administration of hCG, and the appearance of the eggs in
the oviduct, as well as the rate of fertilization, was exam-
ined. Although the appearance of the ampulla in the
oviduct was similar, the ova released after the animals
were treated with hCG still failed to become fertilized. In
addition, ova and their cumulus complexes from Ep2–/–
animals were morphologically indistinguishable from
those from wild-type controls. Therefore, it seems unlike-
ly that the decreased fertilization of eggs from Ep2–/– mice
results from an alteration in the timing of ovulation.
The fertilization process requires successful transport of
sperm to the oviducts, where they can be sequestered for
interaction with the ova. PGs have been shown to facilitate
sperm transport through the female reproductive tract,
not only by their actions on sperm but also by their effects
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Figure 4
Renin mRNA levels in Ep2–/– and Ep2+/+ mice. RNA was obtained from
the kidneys of Ep2–/– (n = 8) and Ep2+/+(n = 7) mice on a normal diet
(0.4% NaCl), and renin mRNA levels were determined by RNase protec-
tion assay. Data represent mean ± SEM.
Table 2
Average resting systolic blood pressure of Ep2–/– and Ep2+/+ mice
Diet Ep2–/– n Ep2+/+ n
NDA 109 ± 3C,D 14 122 ± 5C 13
HDB 117 ± 3D 14 126 ± 4 14
ANormal diet (0.4% NaCl). BHigh-salt diet (6% NaCl). CP = 0.04. DP = 0.01.
on female reproductive tissue, including oviductal
smooth muscle (24). Numerous sperm were found in the
oviducts of Ep2–/– females within 12 hours of coitus, mak-
ing it unlikely that alteration in sperm transport is the
cause of fertilization failure in the EP2-deficient animals.
Together, these findings suggest that the reduced fertil-
ization seen in these animals could be a function of PGs
intrinsic to the ovum and cumulus cells, or that EP2-
mediated PGE2 functions are essential for establishing an
oviductal microenvironment conducive to successful fer-
tilization. To distinguish between these 2 possibilities, we
compared in vitro and in vivo fertilization of the Ep2–/–
ovum. Successful in vitro fertilization of ova from Ep2–/–
animals does not support the former hypothesis. These
results are consistent with studies showing that matura-
tion of the ovum is independent of PGs (25, 26). Previous
studies have also suggested that ovum viability is unaf-
fected by inhibitors of PG synthesis in vitro (5).
Our studies are consistent with the hypothesis that
PGE2 acts through the EP2 receptor to define a microen-
vironment in the oviduct conducive to fertilization.
Although such a function in reproductive physiology
has not previously been ascribed to these lipids, it is con-
sistent with the diverse actions of PGs in numerous
organ systems. For example, PGs have been shown to
modify ion transport in a number of epithelia (27, 28). It
is possible that the ionic composition of the oviductal
fluid is altered in the Ep2–/– animals and that this, in
turn, leads to reduced fertilization.
PGE2 also has potent effects on the cardiovascular sys-
tem. A role for PGE2 in blood pressure homeostasis has
been recognized for years, but these actions are complex,
involving regulation of vascular tone and sodium bal-
ance (17). To examine the role of the EP2 receptor in
blood pressure regulation, we measured systolic blood
pressure in conscious Ep2–/– animals. On a normal diet
(0.4% NaCl), systolic blood pressure was reduced by 13
mmHg in the EP2-deficient mice compared with con-
trols. To determine whether this difference in blood pres-
sure could be overcome by providing excess sodium in
the diet, Ep2–/– and Ep2+/+ mice were fed high-salt diets
containing 6% NaCl (wt/wt). This increase in dietary
NaCl content had no effect on blood pressures in the
wild-type mice. In contrast, on the high-salt diet, blood
pressure increased significantly in Ep2–/– mice to levels
that were not significantly different than controls. Thus,
reduced blood pressure in the Ep2–/– mice is sodium sen-
sitive and can be overcome with dietary sodium loading.
This suggests that the absence of EP2 receptors produces
an abnormality in sodium handling by the kidney. EP2
receptor expression in the kidney has been demonstrat-
ed by both RT-PCR and Northern analysis (29, 30),
although its cellular functions in the kidney have not
been clearly elucidated.
Our findings of reduced blood pressure in the Ep2–/–
animals may seem somewhat paradoxical given the
known vasorelaxant actions of PGE2 (31, 32). However,
whereas acute infusions of PGE2 cause vasodilation,
chronic infusions of PGE2 increase blood pressure
through direct stimulation of renin secretion (33). Fur-
thermore, inhibitors of PG synthesis have been shown to
lower blood pressure and renin levels in patients with
renovascular hypertension (34). It is well established that
PGs can stimulate renin release through actions on the
juxtaglomerular apparatus; hormones that increase
intracellular cAMP levels stimulate renin release by these
specialized cells (35). Because 2 EP receptors, EP2 and
EP4, are Gs protein–coupled, it has been suggested that
one or both of these receptors may mediate this action
of PGE2 (28, 36).
To determine whether abnormal regulation of the
renin-angiotensin system might contribute to altered
blood pressure regulation and salt sensitivity in Ep2–/–
mice, we measured PRA in these animals. Despite their
lower blood pressures while on a normal diet, neither
PRA nor renin mRNA was elevated in the Ep2–/– animals
(Figures 3 and 4). This differs from other lines of mice
harboring targeted mutations that lower blood pressure,
where PRA and renin mRNA are consistently elevated as
a compensatory mechanism (20, 37). These findings sug-
gest that renin responses are significantly impaired in
EP2-deficient mice. Failure to stimulate PRA may con-
tribute to the reduced blood pressure seen in these ani-
mals while they are on a normal diet.
The contribution of PGs to many important biologic
processes has been recognized for years. Recently, mice
carrying homozygous null mutations for genes encoding
enzymes in the PG biosynthetic pathway and in PG recep-
tors themselves have furthered our understanding of the
role that these lipid mediators play in various aspects of
reproduction (10, 11). The role of PGs in maintaining cir-
culatory homeostasis has been more controversial and
less understood. Here we define critical roles for the EP2
PGE2 receptor in blood pressure regulation and female
reproduction. Specifically, we present evidence support-
ing the hypothesis that PGE2, acting though the EP2
receptor, is important for establishment of the microen-
vironment required for successful fertilization of the
released ovum. We also show that the EP2 receptor is
essential for normal blood pressure homeostasis. Mice
lacking this receptor are relatively hypotensive, and this
hypotension can be partially reversed by salt loading.
Finally, compensatory increases in renin are not seen in
these animals, suggesting that the EP2 receptor may be
involved in PG-stimulated renin release. Continued inves-
tigations into the specific roles of the receptors that medi-
ate the actions of PGs will further our understanding of
these important lipid mediators and potentially may lead
to the development of more specific and less toxic thera-
pies for a variety of disease processes.
Note added in proof. During the review process of this
manuscript, an analysis of EP2 receptor–deficient mice
was independently reported in the February 1999 issue
of Nature Medicine (5:217–220).
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